Ranbaxy Laboratories Ltd has informed about the following:
- R&D De-merger for Drug Discovery Research (DDR)
Ranbaxy received an in-principle approval from the Board to de-merge its Drug Discovery Research operation. The Company believes that this is a significant step in creating an independent pathway for DDR with dedicated resources and enhanced focus for long-term value building. […]
Orchid Chemicals & Pharmaceuticals Ltd has announced the following unaudited results for the quarter ended September 30, 2007:
The company has posted a net profit after tax of Rs 63.2726 crore for the quarter ended September 30, 2007 as compared to Rs 29.4508 crore for the quarter ended September 30, 2006. Total income has increased from […]
Pharma company Zenotech Laboratories on Friday said drug major Ranbaxy Laboratories have executed definitive agreements towards consolidating its stake in the company.
Earlier this month, Ranbaxy had said that it would increase its stake in Zenotech Labs to 45 per cent for Rs 214 crore and make an open offer to buy an additional up to […]
